Artificial intelligence empowered digital health technologies in cancer survivorship care: A scoping review.

Asia Pac J Oncol Nurs · 2022 · PMC9513729 · PMID 36176267

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Strengths and weaknesses of this study Although this review provides a quality assessment for studies, the few included studies suggest that there may be significant literature in the feasibility of Phase 1 or 2.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.